Advertisement
DBD vs GDRX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBD is a StrongBuy and GDRX is a StrongBuy.
DBD in upward trend: 10-day moving average broke above 50-day moving average on October 22, 2026
The 10-day moving average for DBD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on DBD as a result. In 43 of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for DBD just turned positive on October 01, 2026. Looking at past instances where DBD's MACD turned positive, the stock continued to rise in 23 of 32 cases over the following month. The odds of a continued upward trend are 72%.
DBD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where DBD advanced for three days, in 174 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
DBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for DBD entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. DBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.387) is normal, around the industry mean (-1.734). P/E Ratio (22.275) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.074) among similar stocks. P/S Ratio (0.606) is also within normal values, averaging (71.128).
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
GDRX in upward trend: price rose above 50-day moving average on October 20, 2026
GDRX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 31 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on GDRX as a result. In 72 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for GDRX just turned positive on October 09, 2026. Looking at past instances where GDRX's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
The 10-day moving average for GDRX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.
Following a +2.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where GDRX advanced for three days, in 199 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
GDRX broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GDRX entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. GDRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.907) is normal, around the industry mean (3.981). GDRX has a moderately high P/E Ratio (60.333) as compared to the industry average of (13.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (1.494) is also within normal values, averaging (6.065).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GDRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
GDRX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 88 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 11 | |
SEASONALITY SCORE 1..100 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DBD | GDRX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | N/A |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 88% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 81% |
| Advances ODDS (%) | 1 day ago 79% | 1 day ago 79% |
| Declines ODDS (%) | 15 days ago 60% | 9 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DBD’s FA Score shows that 0 FA rating(s) are green while GDRX’s FA Score has 1 green FA rating(s).
- DBD’s FA Score: 0 green, 5 red.
- GDRX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DBD’s TA Score shows that 6 TA indicator(s) are bullish while GDRX’s TA Score has 4 bullish TA indicator(s).
- DBD’s TA Score: 6 bullish, 3 bearish.
- GDRX’s TA Score: 4 bullish, 5 bearish.
Price Growth
DBD (@Packaged Software) experienced а +4.04% price change this week, while GDRX (@Services to the Health Industry) price change was +5.62% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.42%. For the same industry, the average monthly price growth was -3.95%, and the average quarterly price growth was +4.32%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
Reported Earning Dates
DBD is expected to report earnings on Oct 28, 2026.
GDRX is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Packaged Software (-0.42% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
DBD and
Correlation & Price change
A.I.dvisor indicates that over the last year, DBD has been loosely correlated with GDRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then GDRX could also see price increases.
| Ticker / NAME | Correlation To DBD | 1D Price Change % | ||
|---|---|---|---|---|
| DBD | 100% | +1.61% | ||
| GDRX - DBD | 49% Loosely correlated | +1.40% | ||
| RAMP - DBD | 47% Loosely correlated | +0.10% | ||
| BLZE - DBD | 43% Loosely correlated | -7.82% | ||
| EEFT - DBD | 42% Loosely correlated | +1.73% | ||
| PAYO - DBD | 41% Loosely correlated | +0.14% | ||
More | ||||
GDRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, GDRX has been loosely correlated with CLSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if GDRX jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To GDRX | 1D Price Change % | ||
|---|---|---|---|---|
| GDRX | 100% | +1.40% | ||
| CLSK - GDRX | 53% Loosely correlated | -6.86% | ||
| RIOT - GDRX | 53% Loosely correlated | -8.06% | ||
| COIN - GDRX | 51% Loosely correlated | -4.51% | ||
| DBD - GDRX | 48% Loosely correlated | +1.61% | ||
| COMP - GDRX | 48% Loosely correlated | +2.57% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DEUS | 67.25 | 0.69 | +1.04% |
| Xtrackers Russell US Multifactor ETF (DEUS) | |||
| TMYY | 19.98 | -0.14 | -0.67% |
| GraniteShares YieldBOOST TSM ETF (TMYY) | |||
| PTNQ | 84.93 | -2.58 | -2.95% |
| Pacer Trendpilot 100 ETF (PTNQ) | |||
| FAZ | 33.30 | -1.10 | -3.20% |
| Direxion Daily Financial Bear 3X ETF (FAZ) | |||
| AAOG | 0.85 | -0.26 | -23.74% |
| Leverage Shares 2X Long AAOI Daily ETF (AAOG) | |||